Treating coronavirus infection with azithromycin doesn’t seem to make sense, new research says.
The antibiotic azithromycin, which is prescribed to patients with coronavirus, does not improve their condition. When treating COVID-19, it is better to completely abandon this drug until the bacteria become addicted to it.
Earlier, virologists from France stated that azithromycin helps in the treatment of coronavirus, and the combination of azithromycin and the antimalarial agent hydroxychloroquine significantly reduces the severity of COVID-19.
- Does This Mean We Stopped Being Animal and Started Being Human Due to ‘Copy Paste’ Errors?
- The One Lifestyle Choice That Could Reduce Your Heart Disease Risk By More Than 22%
- Aging: This Is What Happens Inside Your Body Right After Exercise
- Immune-Boosting Drink that Mimics Fasting to Reduce Fat – Scientists ‘Were Surprised’ By New Findings
- Gun Violence in America: What They Don’t Talk About at the Debate
Scientists from the University of California at San Francisco with scientists from Stanford University conducted a study and found that the use of azithromycin by COVID patients did not reduce their risk of entering intensive care or death from infection.
“It is important that doctors around the world in the near future stop using this drug to fight COVID-19, which will reduce the risk that bacteria will begin to acquire resistance to its action,” American and British experts say.
They conducted a study involving 298 people who were diagnosed with the coronavirus.
Patients with mild to moderate forms of the disease taking high doses of azithromycin did not improve their condition.
In severely ill patients, the antibiotic did not reduce their likelihood of being admitted to intensive care.
These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection
the scientists concluded.
Most of the trials done so far with azithromycin have focused on hospitalized patients with pretty severe disease.
Our paper is one of the first placebo-controlled studies showing no role for azithromycin in outpatients.
Photo by Dimitar DILKOFF / AFP) (Photo by DIMITAR DILKOFF/AFP via Getty Images